New Antiviral Stops Long COVID in Mice, Scientists Report

A breakthrough antiviral compound has halted long COVID symptoms in mice, offering new hope for human treatments. Here’s what researchers discovered in 2025.

Next-Gen COVID-19 Vaccines by INOVIO, Ocugen, Pfizer in 2025

Explore the latest COVID-19 vaccines in development by INOVIO, Ocugen, and Pfizer. Learn about new delivery platforms and what’s next in SARS-CoV-2 protection.

Why So Many Rapid COVID Tests Are Made in China?

Explore why Chinese companies dominate rapid COVID test manufacturing and which brands currently originate from China. Learn what this means for global health.

How 2025 Economic Turmoil May Affect COVID-19 Worldwide

U.S. economic turmoil and shifting federal policies in 2025 may threaten COVID-19 funding, surveillance, and vaccine access. Learn what’s at stake at home and abroad.

China Tariffs and Why to Buy U.S. COVID Rapid Tests

Explore how U.S. tariffs on China may raise costs for iHealth rapid COVID tests and why American-made tests are a smarter, more reliable choice in 2025.

Could New US Tariffs Impact COVID-19 Measures?

Explore whether the new US tariffs could affect COVID-19 response and supply chains, and if lingering pandemic effects may shape tariff policies in 2025.

WHO COVID-19 Global Trends in April 2025

Explore the latest WHO COVID-19 data tracker insights from April 2025, including global case trends, variant updates, and health responses.

Leading Theories on the Origins of SARS-CoV-2 in 2025

Explore the top theories about where COVID-19 began, including lab-leak and zoonotic spillover origins, based on current public health and scientific insights.

Current COVID-19 Travel Restrictions Remaining in March 2025

Explore the latest COVID-19 travel restrictions as of March 2025, including updates on North Korea’s border policies and potential U.S. travel bans.

Impact of U.S. Tariffs on COVID-19 Health Supplies and Availability

How recent tariffs on imports affects the availability and cost of health supplies essential for managing COVID-19, including pharmaceuticals.